SCAP and type 1 diabetes mellitus: Western blotting of extracts of brains from streptozotocin (STZ)-treated mice (a model of type 1 diabetes) revealed an ∼50% decrease in SCAP protein in the mouse cerebral cortex (Figure 1A).